Special Issue "Transition from Nutraceuticals to Nano-Nutraceuticals and Nano-Pharmaceuticals: Impact on Health and Diseases"
Deadline for manuscript submissions: closed (15 December 2019) | Viewed by 4208
2. Vascular Vision Pharmaceuticals Co., Rensselaer Polytechnic Park, Troy, NY 12180 USA
Interests: pharmaceuticals; biopharmaceuticals and diagnostics; nanomedicine; cardiovascular diseases; neurological disorders; hematology and oncology; biosimilar and nanosimilar; angiogenesis; inflammation; thrombosis; integrin and cell adhesion molecules; target identification; molecular mechanisms and signaling pathways; preclinical; clinical; marketing and post marketing studies; regulatory and ethical issues
Special Issues, Collections and Topics in MDPI journals
Special Issue in Cancers: Cancer Cell Imaging
Special Issue in International Journal of Molecular Sciences: Vascular Biology and Therapeutics
Special Issue in Biomedicines: Anti-Angiogenesis Therapeutics in Cancer
Special Issue in Biomedicines: Impact of Nanobiotechnology (Nanomedicine) on the Future of Medicine: The Road toward Precision Medicine
Special Issue in Biomedicines: Selected Papers in the 1st International Electronic Conference on Biomedicine (ECB 2021)
Special Issue in Biomedicines: Anti-angiogenesis Therapeutics in Cancer, Ocular and Skin Disorders
Special Issue in Biomedicines: Impact of Nanobiotechnology (Nanomedicine) on the Future of Medicine: The Road toward Precision Medicine 2.0
Special Issue in Biomedicines: Biomedicines: 10th Anniversary
Special Issue in Biomedicines: Selected Papers in the 2nd International Electronic Conference on Biomedicines (ECB 2023)
Topical Collection in Biomedicines: Advanced Biomedical Science and Technology
Medicinal plants have been utilized in all societies as a wellspring of therapeutic use and drug discovery. Traditional medication utilizes plant-, animal-, and marine-based drugs; spiritual treatments; and manual procedures and activities to treat, diagnose, and avert illnesses. In spite of advancements in recent decades with regard to therapeutics, pharmacological approaches, and new restorative innovations, a high percentage of the population still depends on traditional medicine for their essential health care needs. Despite the fact that fruitful or successful traditional medication use has not always been realized, there remains a strong reliance on a huge range of natural products isolated from plants, animals, and some microorganism or marine sources. Natural medications used to treat various illnesses for long periods of time have provided a significant incentive to the cutting-edge pharmaceutical industry over the past 50 years.
In this Special Issue, we will feature the advancement accomplished in the most recent decades in traditional medicines inspired by natural products. Additionally, we will consider how natural products utilized in the past gave a valuable platform to the advancement of pharmaceutical industry, and current approaches to going from nature, to the bench, to the bedside. Furthermore, to truly capitalize on such approaches, pharmacokinetic (PK), pharmacodynamics (PD, efficacy), and safety regarding traditional medicine quality, use, and standardization will be addressed.
The impact of nanobiotechnology on improving the PK and PD of nutraceuticals, which would accelerate the transition from nutraceuticals to nano-nutraceuticals to pharmaceuticals and nanopharmaceuticals, will be a key emphasis of this Special Issue.
Prof. Dr. Shaker Mousa
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- nano nutraceuticals
- nutraceuticals to pharmaceuticals
- alternative and complimentary medicine
- natural products
- herbal medicines
- disease prevention
- plant bioactive compounds
- marine- and animal-derived products